These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23745189)

  • 21. Current status of bioanalytical outsourcing: a pharma perspective.
    Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical futures: made in China?
    Cyranoski D
    Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
    [No Abstract]   [Full Text] [Related]  

  • 23. Create products by going virtual.
    Hogan J
    Med Device Technol; 2005 Nov; 16(9):38-9. PubMed ID: 16438448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-quarter biotech job picture.
    Francisco M
    Nat Biotechnol; 2012 Aug; 30(8):803. PubMed ID: 22871722
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
    Dierks RML; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outsourcing to China.
    Liu J
    Med Device Technol; 2004 Dec; 15(10):15-6. PubMed ID: 16225277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 28. Careers. Joining a trend, scientists increasingly say 'call my agent'.
    Gura T
    Science; 2004 Jan; 303(5656):303-5. PubMed ID: 14726569
    [No Abstract]   [Full Text] [Related]  

  • 29. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 30. Is it virtuous to be virtual? The VC viewpoint.
    Chakma J; Calcagno JL; Behbahani A; Mojtahedian S
    Nat Biotechnol; 2009 Oct; 27(10):886-8. PubMed ID: 19816436
    [No Abstract]   [Full Text] [Related]  

  • 31. First-quarter biotech job picture.
    Francisco M
    Nat Biotechnol; 2014 May; 32(5):497. PubMed ID: 24811521
    [No Abstract]   [Full Text] [Related]  

  • 32. This Dutchman is flying.
    Watson N
    Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
    [No Abstract]   [Full Text] [Related]  

  • 33. AbbVie buys last available priority voucher for $350 million.
    Morrison C
    Nat Biotechnol; 2015 Nov; 33(11):1120. PubMed ID: 26544127
    [No Abstract]   [Full Text] [Related]  

  • 34. Golden opportunities.
    Smaglik P
    Nature; 2005 Jul; 436(7047):144-7. PubMed ID: 16007735
    [No Abstract]   [Full Text] [Related]  

  • 35. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 36. Japanese firms broaden investment focus to early biotech.
    Louët S; Sipp D
    Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
    [No Abstract]   [Full Text] [Related]  

  • 37. A quiet revolution in lead optimisation services?
    Cavalla D
    Drug Discov Today; 2004 Aug; 9(15):635-6. PubMed ID: 15279844
    [No Abstract]   [Full Text] [Related]  

  • 38. The extended pharmaceutical enterprise.
    Cavalla D
    Drug Discov Today; 2003 Mar; 8(6):267-74. PubMed ID: 12623241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hatteras rounds up $90 million to lead biotech rebound in North Carolina.
    Erickson D
    Nat Biotechnol; 2015 Nov; 33(11):1121-2. PubMed ID: 26544128
    [No Abstract]   [Full Text] [Related]  

  • 40. Roche chases stake in medical sequencing.
    Hayden EC
    Nature; 2012 Apr; 484(7393):152. PubMed ID: 22498604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.